
Fourth Quarter and Full Year 2024 Results
Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.
Upcoming Events
25Mar
2025
BNP Paribas Exane Healthcare Conference
08:00 Virtual
Broker Conference
26Mar
2025
Goldman Sachs Innovation Clinic Event
08:00 - 15:00 GMT (London)
Broker Conference
Press Releases
March 20, 2025
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
March 8, 2025
Press Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
March 5, 2025
Press release: Sanofi successfully prices EUR 1.5 billion of bond issue

Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Subscribe to investor email alerts
Sign up to receive email alerts for various types of investor content
Contact Our Investor Relations Team
To join the Sanofi front desk,
Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00
To contact the Investor Relations team:
46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com